Skip to main content
Erschienen in: Netherlands Heart Journal 1/2014

Open Access 01.01.2014 | Rhythm Puzzle - Answer

Saturday night broad QRS complex tachycardia in a young male

verfasst von: J. E. C. van de Swaluw, R. van Mechelen

Erschienen in: Netherlands Heart Journal | Ausgabe 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Answer to the rhythm puzzle

The ECG in the question (Fig. 1) shows a regular wide complex tachycardia with a rate of 237 beats/min with changing QRS width. The QRS axis is negative in II, III, aVF and positive in aVR suggesting an extreme right axis deviation. The QRS complexes show a right bundle branch block (RBBB)-like morphology. The QRS complexes in V6 show an RS pattern. There is no monomorphic R wave in aVR and the QRS duration varies. This is clearly seen in leads II, III, aVF and V1 when one compares the width of the first six with the last three QRS complexes. There is no AV dissociation and there are no fusion or escape beats. In lead III there is a notch visible in the initial part of the ST segments of the first six QRS complexes. In lead II there is a notch visible in the terminal part of the ST segments of the last five QRS complexes.
According to the classical Wellens criteria this tachycardia shows a right bundle branch block morphology. It is of supraventricular origin because there is no left axis deviation, a relatively narrow QRS width of 140 ms and the absence of a monomorphic R wave or left rabbit ear sign in the first eight beats of lead V1 [1].
According to the criteria of Brugada, there are RS complexes in the precordial leads, the longest R-S interval is less than 100 ms, there is no AV dissociation and the classical criteria for ventricular tachycardia (VT) in the precordial leads are missing [2].
The criteria for VT presented by Verreckei et al. are by far the easiest to apply [3]. These investigators came up with the idea to look purely at the QRS morphology in lead aVR. According to their criteria there is no monomorphic R wave in aVR, there is no initial q wave greater than 40 ms and there is no initial delay or notch in the initial part of the QRS complex in lead aVR. However, the vertical excursion of the QRS in the last 40 ms is larger than in the first 40 ms and therefore suggests VT.
Spontaneously the ECG changes (Fig. 2). It demonstrates group beating at a rate of 167 beats/min with two types of QRS complexes, i.e. narrow QRS complexes with left axis deviation and a slightly wider QRS complex with incomplete RBBB morphology. The RR-time differs between the two types as is shown in lead 2.
Lead V1 demonstrates an atrial flutter waves with a FF interval of 240 ms with 3:2 AV Wenckebach conduction to the ventricles. Every third flutter wave is not conducted to the ventricles.
What is interestingly to note is that the first conducted flutter wave to the ventricles produces a narrow QRS complex. Paradoxically, the second wave with a more prolonged AV nodal conduction time produces an incomplete RBBB and the third flutter wave is blocked in the AV node.
In conclusion, the initial ECG showed an atrial flutter at a rate of approximately 240 bpm with 1:1 AV conduction to the ventricles with RBBB aberrancy.
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Wellens HJJ, Bar FWHM, Lie KI. The value the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med. 1978;64:27–33.PubMedCrossRef Wellens HJJ, Bar FWHM, Lie KI. The value the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med. 1978;64:27–33.PubMedCrossRef
2.
Zurück zum Zitat Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83:1649–59.PubMedCrossRef Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83:1649–59.PubMedCrossRef
3.
Zurück zum Zitat Vereckei A, Duray G, Szénási G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89–98.PubMedCrossRef Vereckei A, Duray G, Szénási G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89–98.PubMedCrossRef
Metadaten
Titel
Saturday night broad QRS complex tachycardia in a young male
verfasst von
J. E. C. van de Swaluw
R. van Mechelen
Publikationsdatum
01.01.2014
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 1/2014
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-013-0489-5

Weitere Artikel der Ausgabe 1/2014

Netherlands Heart Journal 1/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.